Bubenreuth, Germany

Detlef Schuppan



Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 74(Granted Patents)


Location History:

  • 12163 Berlin, DE (2001)
  • Bubenreuth, DE (2006 - 2010)

Company Filing History:


Years Active: 2001-2010

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Detlef Schuppan in Liver Disease Research**

Introduction

Detlef Schuppan is a prominent inventor based in Bubenreuth, Germany, known for his significant contributions to the field of liver disease research. With a total of five patented inventions, Schuppan has demonstrated a commitment to developing advanced diagnostic methods and treatment modalities aimed at improving patient outcomes. His innovative work combines cutting-edge science with practical applications that can aid in the management of liver conditions.

Latest Patents

Among Schuppan's latest patents is a groundbreaking invention titled "Liver disease-related methods and systems." This invention introduces diagnostic methods, kits, and systems, as well as related computer-readable media, which utilize multiple blood marker values, including serum and plasma marker values. These tools aid in diagnosing the status or progress of liver disease in patients. Moreover, the invention provides methodologies for screening active ingredients for liver disease treatments, assisting in selecting appropriate treatment regimens, and designing clinical programs for monitoring liver conditions.

Another significant patent by Schuppan focuses on "Compositions and methods for inhibiting expression of anti-apoptotic genes." This invention involves a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of anti-apoptotic genes, particularly targeting parts of apoptotic genes such as Bcl genes. The patent also encompasses a pharmaceutical composition that includes the dsRNA alongside a pharmaceutically acceptable carrier, as well as methods for treating diseases linked to the expression of anti-apoptotic genes.

Career Highlights

Throughout his career, Schuppan has worked with a variety of organizations, enhancing his expertise and influence in the research community. Notably, he collaborated with Alnylam Europe AG, an entity that focuses on RNA interference therapeutics. His extensive knowledge in liver disease has positioned him as a key innovator in this vital medical field.

Collaborations

Detlef Schuppan has collaborated with other talented professionals in his field, including Werner Kroll and Andreas Knorr. These collaborations have fostered a dynamic exchange of ideas and expertise, leading to the development of innovative solutions for complex health issues related to liver diseases.

Conclusion

Detlef Schuppan's contributions to the realm of liver disease research are profound and far-reaching. His innovative patents not only provide diagnostic and therapeutic advancements but also pave the way for improved patient care and outcomes. As research continues to evolve, Schuppan remains a notable figure in the movement towards better understanding and treatment of liver conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…